About Credo Pharma Private Limited
Data last updated:
Credo Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC089087. Its GSTIN is 36AAFCC3414L1ZP (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹1.13 Cr. It is led by directors including Aluru Narmada and Kandru Madhavarao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No:102 Aditya Trade Centre Ameerpet, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.15 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹5.05 Lakh (net margin -2.4%) and EBITDA of -₹4.25 Lakh (EBITDA margin -2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 12% over five years.
The company is associated with 1 brand: Credo Pharma. As per MCA filings, the company has satisfied charges of ₹3.1 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹62.5 Lakh; the latest was in March 2015.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website credopharma.com.
Company details
CIN history
Credo Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC089087. The current CIN is U24232TG2013PTC089087, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC089087 | Current |
| U24232AP2013PTC089087 | Previous |
Contact details
Credo Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is credopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No:102 Aditya Trade Centre Ameerpet, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Credo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Credo Pharma operates one associated brand: Credo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Integrated firm for manufacturing and trading niche pharmaceutical molecules. | credopharma.com |
Business activity
The main business activity of Credo Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Credo Pharma Private Limited, buy the company report.
Financials of Credo Pharma Private Limited
FY 2024 filings availableCredo Pharma Private Limited reported revenue of ₹2.15 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 10% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Credo Pharma Private Limited, buy the company report.
Board of directors of Credo Pharma Private Limited
Credo Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aluru Narmada Also directs: Auctus Life Sciences LLP, Virman Critical Care Services LLP | Director | 24 Mar 2014 | 12 Years 6 Months | Current |
| Kandru Madhavarao Also directs: Credo Life Sciences Private Limited | Director | 23 Jul 2013 | 13 Years 3 Months | Current |
| Siva Rama Prasad Aluru Also directs: Auctus Life Sciences LLP, Credo Life Sciences Private Limited | Director | 01 Jul 2019 | 7 Years 3 Months | Current |
| Aluru Vamsi Krishna Also directs: Auctus Life Sciences LLP, Credo Life Sciences Private Limited | Director | 23 Jul 2013 | 13 Years 3 Months | Current |
Auditor
Credo Pharma Private Limited is audited by K. NAGARAJU & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. NAGARAJU & ASSOCIATES | FY 2024 | 002270S |
Shareholding
The shareholding of Credo Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Credo Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2014 | 10515731 | Hdfc Bank Limited | ₹3.1 Cr | Satisfied |
To see the full charge records of Credo Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Credo Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹62.5 Lakh; the latest was in March 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2014 | Funding round | ₹62.5 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Credo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Credo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Credo Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCC3414L1ZP | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Credo Pharma Private Limited, buy the company report.
Recent activity
Credo Pharma Private Limited has 9 board changes on record since 2013: 4 appointments and 5 cessations. The latest: Siva Rama Prasad Aluru ceased to be Additional Director on 21 Dec 2020.
2 earlier events are in the company report.
Frequently asked questions
Credo Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 July 2013 (13+ years old) and is registered under CIN U24232TG2013PTC089087.
Credo Pharma has 4 current directors:
- Aluru Narmada - Director
- Kandru Madhavarao - Director
- Siva Rama Prasad Aluru - Director
- Aluru Vamsi Krishna - Director
The latest financial statements of Credo Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Credo Pharma is 36AAFCC3414L1ZP, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Credo Pharma is U24232TG2013PTC089087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Credo Pharma was incorporated on 23 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Credo Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹62.5 Lakh; the latest was in March 2015.
Siva Rama Prasad Aluru ceased to be Additional Director on 21 Dec 2020. Siva Rama Prasad Aluru was appointed as Director on 01 Jul 2019. Aluru Vamsi Krishna ceased to be Whole-Time Director on 05 Oct 2018. Credo Pharma has 9 board changes on record in total.
Credo Pharma can be reached through the website credopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Credo Pharma is at Flat No:102 Aditya Trade Centre Ameerpet, Hyderabad, Telangana, India – 500038.